TOFISOPAM: 21 Adverse Event Reports & Safety Profile
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
21
Total FAERS Reports
0
Deaths Reported
12
Hospitalizations
21
As Primary/Secondary Suspect
1
Disabilities
First Report: 20140625 · Latest Report: 20240411
What Are the Most Common TOFISOPAM Side Effects?
#1 Most Reported
Deep vein thrombosis
5 reports (23.8%)
#2 Most Reported
Dizziness
4 reports (19.0%)
#3 Most Reported
Therapy partial responder
3 reports (14.3%)
All TOFISOPAM Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Deep vein thrombosis | 5 | 23.8% | 0 | 5 |
Who Reports TOFISOPAM Side Effects? Age & Gender Data
Gender: 28.0% female, 72.0% male. Average age: 52.0 years. Most reports from: KR. View detailed demographics →
Is TOFISOPAM Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2014 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 0 |
What Is TOFISOPAM Used For?
| Indication | Reports |
|---|---|
| Anxiety disorder | 5 |
Official FDA Label for TOFISOPAM
Official prescribing information from the FDA-approved drug label.